ROIV
Roivant Sciences Ltd.
NasdaqGSUSDEQUITY
DELAYED
Last price
36.36
▼ 0.48 (1.30%)
MARKET · —
Price
Open
37.44
Prev close
36.84
Day high
37.18
Day low
36.23
Volume
5.77M
Market cap
—
P/E (TTM)
—
52W range
11.60 – 37.97
Trailing performance
Returnvs SPY
1W
+0.28%
+1.6%
1M
+3.42%
-0.3%
3M
+17.55%
+14.5%
6M
+33.70%
+22.6%
YTD
+67.28%
+55.0%
1Y
+209.73%
+189.7%
3Y
+235.80%
+161.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
36.38
-0.06% from price
SMA 20
35.38
+2.59% from price
SMA 50
34.47
+5.30% from price
SMA 100
31.65
+14.88% from price
SMA 200
27.75
+30.82% from price
EMA 12
36.21
+0.41% from price
EMA 26
35.46
+2.53% from price
EMA 50
34.27
+6.08% from price
RSI (14)
56.2
Neutral
MACD (12,26,9)
0.75
Hist 0.08
ATR (14)
1.27
3.49% of price
Realised vol 30D
34.0%
Annualised
Bollinger upper
37.93
20, 2σ
Bollinger lower
32.83
20, 2σ
50 / 200 cross
Golden
34.47 vs 27.75
Trend bias
Above 200
+30.82%
Risk profile
Beta vs SPY
1.05
More volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
34.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-12.8%
Peak to trough
Max drawdown 5Y
-79.2%
Peak to trough
ATR 14
1.27
3.49% of price
Beta (reported)
—
5Y monthly, from filing
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Roivant Sciences Insider Sold Shares Worth $24,160,402, According to a Recent SEC Filing
MT Newswires · 3d ago
Is Roivant Sciences’ (ROIV) Cost Discipline Offsetting Slower Revenue Enough to Refresh Its Story?
Simply Wall St. · 13d ago
Is Roivant Sciences (ROIV) Overvalued On First Quarter Results?
Simply Wall St. · 13d ago
Roivant Sciences Ltd. Q1 2026 Earnings Call Summary
Moby · 15d ago
Roivant Sciences Q1 Earnings Call Highlights
MarketBeat · 15d ago
Roivant Sciences Ltd (ROIV) (Q1 2026) Earnings Call Highlights: Strategic Advances and Strong ...
GuruFocus.com · 16d ago
Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates
Zacks · 16d ago
Sector Update: Healthcare Stocks Advance Pre-Bell Thursday
MT Newswires · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.